Session 2: Expanding Frontiers of Genomic Medicine Enabled by Cost-Effective Next Generation Sequencing

Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously. Collecting DNA methylation data by WGBS offers valuable insights into disease origin, predisposition, and treatment response, potentially guiding therapeutic strategies. | Whole genome bisulfite sequencing (WGBS) enables a comprehensive analysis of an individual's DNA methylation profile and has the potential to enhance precision medicine initiatives by addressing both genetic and epigenetic factors simultaneously.

Multiomics - Wikipedia

Best practices for the analytical validation of clinical whole-genome sequencing intended for the diagnosis of germline disease

Frontiers Microbiome in Death and Beyond: Current Vistas and Future Trends

Genomics Archives - Phase Genomics

Genomic medicine: cracking genomes to cure 'incurable' diseases

Frontiers Validation and Clinical Applications of a Comprehensive Next Generation Sequencing System for Molecular Characterization of Solid Cancer Tissues

Past Events

The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world - The Lancet

Frontiers The Role of the European Society of Human Genetics in Delivering Genomic Education

eSymposia On Demand - Keystone Symposia

PMWC - Original & Leading Precision Medicine World Conference

5 Process for the Return of Genetic Results (Session 4) Considerations for Returning Individual Genomic Results from Population-Based Surveys: Focus on the National Health and Nutrition Examination Survey: Proceedings of a